Supplemental disclosure of cash flow and non-cash investing and financing activities

9 Months Ended

Sep. 30, 2013

Supplemental Cash Flow Elements [Abstract]

Supplemental disclosure of cash flow and non-cash investing and financing activities

Supplemental disclosure of cash flow and non-cash investing and financing activities:

Selected cash payments, receipts, and noncash activities are as follows:

	Nine Months Ended September 30,
	2013		2012
Cash paid for interest	$	22,971	$	8,738
Income taxes paid	96,967		—
Purchases of property, plant and equipment financed capital leases	107,259		83,016
Stock issuance of 167,086 shares in lieu of Director's fees	—		184,653
Beneficial conversion related to line of credit with related party	—		514,456
Stock issuance in connection with Earn-Out Liability of 1,174, 915 shares for 2013 and
2,632,576 shares for 2012	5,792,330		3,185,223
Stock issuance of 5,272,004 shares in exchange for convertible debt	5,272,004		—
Company issued shares of 167,183 for cashless exercise	—		167
Stock issuance of 893,267 shares in payment of Convertible Secured Promissory Notes related to acquisition of Surgical Biologics	—		893,267
Tenant improvement incentive	996,866		—